Scinai Immunotherapeutics (SCNI) EPS (Basic) (2014 - 2026)
Scinai Immunotherapeutics (SCNI) posted EPS (Basic) of -$0.0 for Q1 2026, up 52.77% sequentially from -$0.0 in Q2 2025, and up 19.82% YoY from -$0.0 in Q1 2025.
Scinai Immunotherapeutics (SCNI) EPS (Basic) (2014 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported EPS (Basic) for 13 years, with the latest figure at -$0.0 in Q1 2026.
- Quarterly EPS (Basic) rose 19.82% year-over-year to -$0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.0 (up 49.28% YoY) and the FY2025 annual result came in at -$0.0, up 59.14% from the prior year.
- EPS (Basic) grew to -$0.0 in Q1 2026 per SCNI's latest filing, from -$0.0 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.09 in Q2 2022 and troughed at -$0.3 in Q4 2022.
- A 5-year average of -$0.02 and a median of -$0.0 in 2026 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 485.02% in 2022, then jumped 13427618.47% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.3 in 2022, then surged by 87.94% to -$0.04 in 2023, then jumped by 96.87% to -$0.0 in 2024, then surged by 69.41% to -$0.0 in 2025, then surged by 52.77% to -$0.0 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.0, -$0.0, and -$0.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 0.18 |
| 10 | Scinai Immunotherapeutics | 13.42 Mn | -3.10 Bn | -1.12 Mn | -0.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | -0.03 |
| Dec 31, 2021 | 0.08 |
| Sep 30, 2021 | -0.95 |
| Jun 30, 2021 | -1.01 |
| Mar 31, 2021 | -0.23 |
| Dec 31, 2020 | -3.45 |